0001193125-22-036017.txt : 20220211 0001193125-22-036017.hdr.sgml : 20220211 20220211092652 ACCESSION NUMBER: 0001193125-22-036017 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220211 DATE AS OF CHANGE: 20220211 GROUP MEMBERS: FORBION I MANAGEMENT B.V. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88012 FILM NUMBER: 22617118 BUSINESS ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP BUSINESS PHONE: 1-339-970-7000 MAIL ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ForUniqure B.V. CENTRAL INDEX KEY: 0001740338 IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NAARDEN STATE: P7 ZIP: 1411 BUSINESS PHONE: 31 35 6993000 MAIL ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NAARDEN STATE: P7 ZIP: 1411 SC 13G/A 1 d294772dsc13ga.htm SC 13G/A SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

 

 

uniQure N.V.

(Name of Issuer)

Common Stock, par value EUR 0.05 per share

(Title of Class of Securities)

N90064101

(CUSIP Number)

31 DECEMBER 2021

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

 

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 90064101    13G/A    Page 2 of 6 Pages        

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

  ForUniQure B.V.

  2.  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

  (a)  ☐        (b)  ☐

  3.  

  SEC USE ONLY

 

  4.  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  The Netherlands

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5.    

  SOLE VOTING POWER

 

  0

   6.  

  SHARED VOTING POWER

 

  546,166

   7.  

  SOLE DISPOSITIVE POWER

 

  0

   8.  

  SHARED DISPOSITIVE POWER

 

  546,166

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  546,166

10.  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

  ☐

11.  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  1.29%(1)

12.  

  TYPE OF REPORTING PERSON

 

  OO

 

 

1

This calculation assumed that there are 46,214,244 Ordinary Shares outstanding as set forth in UniQure N.V.’s (the “Issuer”) quarterly report on Form 10-Q filed with the Securities and Exchange Commission (the “Commission”) on October 25, 2021.


CUSIP No. 90064101    13G/A    Page 3 of 6 Pages        

 

  1.    

  NAMES OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Forbion I Management B.V.

  2.  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

  (a)  ☐        (b)  ☐

  3.  

  SEC USE ONLY

 

  4.  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  The Netherlands

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5.    

  SOLE VOTING POWER

 

  0

   6.  

  SHARED VOTING POWER

 

  546,166

   7.  

  SOLE DISPOSITIVE POWER

 

  0

   8.  

  SHARED DISPOSITIVE POWER

 

  546,166

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  546,166

10.  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

  ☐

11.  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  1.29%(2)

12.  

  TYPE OF REPORTING PERSON

 

  OO

 

 

2

This calculation assumed that there are 46,214,244 Ordinary Shares outstanding as set forth in UniQure N.V.’s (the “Issuer”) quarterly report on Form 10-Q filed with the Securities and Exchange Commission (the “Commission”) on October 25, 2021.


CUSIP No. 90064101    13G/A    Page 4 of 6 Pages        

 

Item 1(a). Name of Issuer:

uniQure N.V.

Item 1(b). Address of Issuer’s Principal Executive Offices:

Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands

Item 2(a). Name of Person Filing:

This Statement is being filed by ForUniQure B.V. (“ForUniQure”), and Forbion 1 Management B.V. (“Forbion 1”), the director of ForUniQure. ForUniQure and Forbion 1 are sometimes referred to collectively herein as the “Reporting Persons”.

Item 2(b). Address of Principal Business Office or, if None, Residence:

The address of the principal business and principal office of each of the Reporting Persons is c/o Forbion Capital Partners, Gooimeer 2-35, 1411 DC Naarden, The Netherlands.

Item 2(c). Citizenship:

ForUniQure B.V. – The Netherlands

Forbion 1 Management B.V. – The Netherlands

Item 2(d). Title of Class of Securities:

Common Stock, par value €0.05 per share

Item 2(e). CUSIP Number:

N90064101

Item 3.

Item 4. Ownership.

ForUniQure is the beneficial owner of 546,166 shares of Common Stock (the “Shares”). ForUniQure acquired the Shares as part of an internal restructuring by Forbion Capital Partners. Forbion 1, the director of ForUniQure, has voting and investment power over the shares held by ForUniQure, which are exercised through Forbion’s investment committee, consisting of H. A. Slootweg, M. A. van Osch, G. J. Mulder and S. J. H. van Deventer. None of the members of the investment committee have individual voting and investment power with respect to such shares, and the members disclaim beneficial ownership of such shares except to the extent of their proportionate pecuniary interests therein.

 

  (a)

Amount beneficially owned: 546,166

 

  (b)

Percent of class: 1.29%


CUSIP No. 90064101    13G/A    Page 5 of 6 Pages

 

The foregoing percentage is calculated 46,214,244 Ordinary Shares outstanding as set forth in UniQure N.V.’s (the “Issuer”) quarterly report on Form 10-Q filed with the Securities and Exchange Commission (the “Commission”) on October 25, 2021.

 

  (c)

Number of shares as to which such person has:

 

  (i)

Sole power to vote or to direct the vote: 0

 

  (ii)

Shared power to vote or to direct the vote: 546,166

 

  (iii)

Sole power to dispose or to direct the disposition of: 0

 

  (iv)

Shared power to dispose or to direct the disposition of: 546,166

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ☒.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

Item 8. Identification and Classification of Members of the Group.

The Reporting Persons are making this single, joint filing because they may be deemed to constitute a “group” within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Reporting Persons disclaim membership in a group and this report shall not be deemed an admission by any of the Reporting Persons that they are or may be members of a “group” for purposes of Rule 13d-5 or for any other purpose.

Item 9. Notice of Dissolution of Group.

Not applicable.

Item 10. Certification.

Not applicable .


CUSIP No. 90064101    13G/A    Page 6 of 6 Pages        

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: February 11, 2022

 

FORUNIQURE B.V.
By:   /s/ V. Van Houten                    /s/ H.A. Slootweg
  Name: V. van Houten                    H.A. Slootweg
  Title: Directors of its director
FORBION 1 MANAGEMENT B.V.
By:   /s/ V. Van Houten                    /s/ H.A. Slootweg
  Name: V. van Houten                    H.A. Slootweg
  Title: its Directors